Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-09-27 4:05 pm Purchase |
2023-09-27 | 13D | Liminal BioSciences Inc. LMNL |
Thomvest Asset Management Ltd. | 3,249,534 100.000% |
867,175 (+36.40%) |
Filing History |
| 2023-07-12 7:09 pm Unchanged |
2023-07-12 | 13D | Liminal BioSciences Inc. LMNL |
Thomvest Asset Management Ltd. | 2,382,359 68.090% |
0 (Unchanged) |
Filing History |
| 2023-04-05 07:30 am Purchase |
2023-04-04 | 13D | Liminal BioSciences Inc. LMNL |
Thomvest Asset Management Ltd. | 2,382,359 68.090% |
2,382,359 (New Position) |
Filing History |
| 2021-02-17 3:13 pm Sale |
2020-12-31 | 13G | Liminal BioSciences Inc. LMNL |
Consonance Capital Management LP | 0 0.000% |
-605,851 (Position Closed) |
Filing History |
| 2021-02-16 2:21 pm Purchase |
2020-12-31 | 13G | Liminal BioSciences Inc. LMNL |
Consonance Capital Management LP | 605,851 11.000% |
277,119 (+84.30%) |
Filing History |
| 2020-11-25 9:50 pm Purchase |
2020-11-25 | 13D | Liminal BioSciences Inc. LMNL |
Thomvest Asset Management Ltd. | 2,399,223 71.600% |
78,947 (+3.40%) |
Filing History |
| 2020-11-06 8:00 pm Purchase |
2020-10-29 | 13D | Liminal BioSciences Inc. LMNL |
Thomvest Asset Management Ltd. | 2,320,276 70.900% |
2,320,276 (New Position) |
Filing History |